Selank
13 indexed publications · 4 human studies · research from 2001 to 2022
Research goals studied
- Immune function
- Mood, stress & sleep
- Neuro & cognition
Studies referencing Selank
Selank Effects on Morphine Withdrawal
2022 · Preclinical
Reported changes in withdrawal-related behavior in rodents.
Selank Modulates Cytokines under Social Stress
2021 · Preclinical
Reported cytokine changes in a rodent social-stress model.
Effects of Semax and Selank on Resting-State Functional Connectivity
2020 · Human evidence
Examined acute changes in resting-state network connectivity after intranasal peptides in healthy participants.
Selank Effects on Ethanol-Associated Memory and BDNF Expression
2019 · Preclinical
Reported memory and BDNF-related effects in rodents exposed to ethanol.
Interaction of Selank with Diazepam in Anxiety Models
2017 · Preclinical
Compared Selank, diazepam and combination effects in behavioral models.
Peptides Semax and Selank Affect the Behavior of Rats with 6-OHDA-Induced Dopaminergic System Damage
2017 · Preclinical
Compared behavioral effects of Semax and Selank after 6-OHDA dopaminergic injury.
Combined Use of Selank in Anxiety Treatment
2015 · Human evidence
Clinical report of Selank within an anxiety-treatment regimen; controlled replication is limited.
Selank in Alcohol Withdrawal
2014 · Preclinical
Reported effects on withdrawal-related behavior in rodents.
Immunomodulatory Effects of Selank in Patients with Anxiety-Asthenic Disorders
2008 · Human evidence
Clinical report evaluating immune parameters during Selank treatment.
Clinical Efficacy of Selank in Generalized Anxiety Disorder and Neurasthenia
2008 · Human evidence
A 62-patient clinical report comparing anxiolytic outcomes; methodological details require full-text review.
Tuftsin-Family Peptide Selank in Stress-Related Responses
2003 · Preclinical
Reported stress-modulating effects of a tuftsin analogue in rodents.
Effect of Selank on Learning and Memory in Rats
2003 · Preclinical
Reported changes in learning and memory tasks in rats.
Semax and Selank Inhibit Enkephalin-Degrading Enzymes in Human Serum
2001 · Preclinical
Tested effects of Semax and Selank on enzymes involved in enkephalin degradation.
Working with Selank?
Convert a vial to draw volume on the peptide calculator, or track protocols and vials in the free app.
Start tracking free